Φορτώνει......
Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia
Dihydrofolate reductase (DHFR) has an important function in DNA synthesis and is a target of methotrexate, which is a crucial treatment option for acute lymphoblastic leukemia (ALL). However, the number of studies conducted to date on DHFR expression in childhood ALL is limited. The aim of the prese...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Oncol Lett |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
D.A. Spandidos
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5950508/ https://ncbi.nlm.nih.gov/pubmed/29805575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8429 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|